Stock-Based Compensation (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	May. 31, 2010
Stock-Based Compensation
Total stock-based compensation	$ 2.2	$ 2.1	$ 5.8	$ 7.1
Stock options, additional information
Fair value of the Company's common stock price (in dollars per share)	$ 16.43		$ 16.43
Stock options
Stock-Based Compensation
Total stock-based compensation	$ 2.0	1.7	$ 5.3	$ 4.7
Risk-free interest rate, minimum (as a percent)			1.58%	1.81%
Risk-free interest rate, maximum (as a percent)			1.89%	2.10%
Volatility, minimum (as a percent)			36.09%	53.24%
Volatility, maximum (as a percent)			52.23%	56.24%
Expected dividend yield (as a percent)			0.00%	0.00%
Stock options | Minimum
Stock-Based Compensation
Vesting period			3 years
Expected life			6 years	6 years
Stock options | Maximum
Stock-Based Compensation
Vesting period			5 years
Expected life			6 years 3 months	6 years 3 months
Restricted stock
Stock-Based Compensation
Total stock-based compensation	$ 0.2	$ 0.4	$ 0.5	$ 2.4
Bruker Corporation Stock Plan
Stock-Based Compensation
Common stock authorized for issuance (in shares)					8,000,000
Bruker Corporation Stock Plan | Minimum
Stock-Based Compensation
Vesting period	3 years
Bruker Corporation Stock Plan | Maximum
Stock-Based Compensation
Vesting period	5 years
Bruker Corporation Stock Plan | Stock options
Stock options, Number of Shares
Outstanding at the beginning of the period (in shares)			4,810,588
Granted (in shares)			1,082,819
Exercised (in shares)			(616,052)
Forfeited (in shares)			(324,779)
Outstanding at the end of the period (in shares)	4,952,576		4,952,576
Exercisable at the end of the period (in shares)	2,596,387		2,596,387
Exercisable and expected to vest at the end of the period (in shares)	4,815,917		4,815,917
Stock options, Weighted Average Option Price
Outstanding at the beginning of the period (in dollars per share)			$ 15.24
Granted (in dollars per share)			19.80
Exercised (in dollars per share)			11.68
Forfeited (in dollars per share)			19.16
Outstanding at the end of the period (in dollars per share)	$ 16.42		16.42
Exercisable at the end of the period (in dollars per share)	13.82		13.82
Exercisable and expected to vest at the end of the period (in dollars per share)	$ 16.34		$ 16.34
Stock options, additional information
Weighted Average Remaining Contractual Term, Outstanding			6 years 7 months 6 days
Weighted Average Remaining Contractual Term, Exercisable			4 years 10 months 24 days
Weighted Average Remaining Contractual Term, Exercisable and expected to vest			6 years 6 months
Aggregate Intrinsic Value, Outstanding	$ 9.7		$ 9.7
Aggregate Intrinsic Value, Exercisable	9.0		9.0
Aggregate Intrinsic Value, Exercisable and expected to vest	9.7		$ 9.7
Weighted average fair values of options granted (in dollars per share)			$ 7.82	$ 10.82
Intrinsic value of options exercised			$ 5.1	$ 9.7
Restricted stock, Weighted Average Grant Date Fair Value
Expected pre-tax stock-based compensation expense	$ 18.7		$ 18.7
Weighted average remaining service period			2 years 2 months 12 days
Bruker Corporation Stock Plan | Restricted stock
Restricted stock, Number of Shares
Outstanding at the beginning of the period (in shares)			309,725
Granted (in shares)			130,274
Vested (in shares)			(56,395)
Forfeited (in shares)			(145,857)
Outstanding at the end of the period (in shares)	237,747		237,747
Restricted stock, Weighted Average Grant Date Fair Value
Outstanding at the beginning of the period (in dollars per share)			$ 17.20
Granted (in dollars per share)			19.72
Vested (in dollars per share)			17.02
Forfeited (in dollars per share)			17.42
Outstanding at the end of the period (in dollars per share)	$ 18.49		$ 18.49
Total fair value of shares vested			$ 1.0	$ 3.0
Expected pre-tax stock-based compensation expense	$ 4.1		$ 4.1
Weighted average remaining service period			3 years